PADI2 and rheumatoid arthritis: Even after adjusting for age, smoking history, known RA serologies, DAS28, and current biologic use, anti-PAD2 antibodies remained strongly and significantly associated with a lower frequency of ILD (adjOR = 0.24; p = 0.015) (Figure 2D).